Print

Multifaceted Approach to Alzheimer’s Treatment in a Pill, T3D Therapeutics Reveals  
9/13/2013 7:17:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

There is no known cure for Alzheimer’s, and every promising treatment candidate has failed to produce results in large scale clinical trials. Startup company T3D Therapeutics believes that this is because there may be several Alzheimer’s pathologies which have not been adequately addressed by recent attempts to develop an effective medicine. The current general consensus is that insulin resistance in brain cells, which causes symptoms such as glucose imbalance, insulin imbalance and beta amyloid plaque buildup, could be the potential trigger for Alzheimer’s.

Hey, check out all the research scientist jobs. Post your resume today!

//-->